Vital Biopharmaceutical Insights and Analytics
for Experts from Experts
Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
Learn More
Sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan....Learn More
Featured Webinar
Despite Physicians' Conservative Attitude Towards Biosimilars, TNF-Alpha Inhibitors Stand to Lose $22 Billion in Sales
December 3, 2009...Learn More
View Webinar schedule and archive